Last reviewed · How we verify

NCT06003322

Non - Incised Papilla Versus Single Flap Technique In The Reconstruction Of Intrabony Defect

Status unknown NA Last updated 21 August 2023
What this trial tests

NA trial testing non - Incised Papilla surgical approach NIPSA for intrabony defect in Periodontal Attachment Loss in 20 participants. Status unknown.

Timeline
7 August 2023
Primary endpoint
7 August 2024
7 September 2024

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date7 August 2023
Primary completion7 August 2024
Estimated completion7 September 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

18 and older, any sex, with Periodontal Attachment Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study will aim to assess the effectiveness of the non-Incised Papilla surgical approach NIPSA used for the surgical debridement of deep intraosseous defects compared to the single-flap approach SFA. Primary outcome: interproximal clinical attachment level gain Secondary outcomes: residual probing pocket depth (PPD), pocket depth (PD) reduction, recession (REC), location of the tip of the papilla (TP), width of the keratinized tissue (KT), wound closure (WC), supra-alveolar attachment gain (SUPRA-AG)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Periodontal Attachment Loss

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06003322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing